| 1 | [SID57578374] | Active | EC50 | 10.162 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype [AID2041, Type: confirmatory] | GTP-binding protein (rab7) [Canis lupus familiaris] [gi:164058] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Active | | EC50 | 10.162 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype | | AID | 2041 | | BioAssay type | confirmatory | | Target | GTP-binding protein (rab7) [Canis lupus familiaris] [gi:164058] | | PubMed | | | Data Table |  |
|
| 2 | [SID134964708] | Inactive | EC50 | 20 | High-throughput multiplex microsphere dose response for inhibitors of toxin protease, specifically Lethal Factor protease, compounds from Powder Set 01 [AID624244, Type: confirmatory] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 134964708 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 20 [uM] | | BioAssay | High-throughput multiplex microsphere dose response for inhibitors of toxin protease, specifically Lethal Factor protease, compounds from Powder Set 01 | | AID | 624244 | | BioAssay type | confirmatory | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | | | Data Table |  |
|
| 3 | [SID134964708] | Inactive | EC50 | 20 | High-throughput multiplex microsphere dose response for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, compounds from Powder Set 01 [AID624243, Type: confirmatory] | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 134964708 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 20 [uM] | | BioAssay | High-throughput multiplex microsphere dose response for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, compounds from Powder Set 01 | | AID | 624243 | | BioAssay type | confirmatory | | Target | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] | | PubMed | | | Data Table |  |
|
| 4 | [SID134964708] | Inactive | EC50 | 20 | High-throughput multiplex microsphere dose response for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, compounds from Powder Set 01 [AID624245, Type: confirmatory] | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 134964708 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 20 [uM] | | BioAssay | High-throughput multiplex microsphere dose response for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, compounds from Powder Set 01 | | AID | 624245 | | BioAssay type | confirmatory | | Target | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] | | PubMed | | | Data Table |  |
|
| 5 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype protein [AID2019, Type: confirmatory] | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype protein | | AID | 2019 | | BioAssay type | confirmatory | | Target | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] | | PubMed | | | Data Table |  |
|
| 6 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 activated mutant [AID2020, Type: confirmatory] | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 activated mutant | | AID | 2020 | | BioAssay type | confirmatory | | Target | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] | | PubMed | | | Data Table |  |
|
| 7 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2050, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2050 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 8 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2050, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2050 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 9 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2050, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2050 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 10 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2047, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2047 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 11 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2047, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2047 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 12 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2047, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2047 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 13 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype [AID2045, Type: confirmatory] | Ras-related protein Rab-2 [gi:46577642] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype | | AID | 2045 | | BioAssay type | confirmatory | | Target | Ras-related protein Rab-2 [gi:46577642] | | PubMed | | | Data Table |  |
|
| 14 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant [AID2048, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant | | AID | 2048 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 15 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant [AID2048, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant | | AID | 2048 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 16 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype [AID2055, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype | | AID | 2055 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 17 | [SID57578374] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype [AID2055, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 57578374 | | CID | 2865685 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype | | AID | 2055 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 18 | [SID17454090] | Inactive | IC50 | | MKP-3 in vitro HTS assay [AID425, Type: confirmatory] | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | MKP-3 in vitro HTS assay | | AID | 425 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] | | PubMed | | | Data Table |  |
|
| 19 | [SID17454090] | Inactive | IC50 | | MKP-3 in vitro HTS assay [AID425, Type: confirmatory] | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | MKP-3 in vitro HTS assay | | AID | 425 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] | | PubMed | | | Data Table |  |
|
| 20 | [SID17454090] | Inactive | IC50 | | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target [AID521, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target | | AID | 521 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] | | PubMed | | | Data Table |  |
|
| 21 | [SID17454090] | Inactive | IC50 | | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target [AID521, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target | | AID | 521 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] | | PubMed | | | Data Table |  |
|
| 22 | [SID17454090] | Inactive | IC50 | | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target [AID521, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target | | AID | 521 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] | | PubMed | | | Data Table |  |
|
| 23 | [SID17454090] | Inactive | IC50 | | High Throughput Screening Assay for Hsp70 Inhibitors [AID583, Type: confirmatory] | heat shock 70kDa protein 1A [Homo sapiens] [gi:123271505] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | High Throughput Screening Assay for Hsp70 Inhibitors | | AID | 583 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 1A [Homo sapiens] [gi:123271505] | | PubMed | | | Data Table |  |
|
| 24 | [SID17454090] | Inactive | | | High Throughput Screen for Inhibitors of ER Stress-induced Cell Death [AID1010, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | BioAssay | High Throughput Screen for Inhibitors of ER Stress-induced Cell Death | | AID | 1010 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID8085194] | Inactive | | | HIV-1 RNase H Inhibition [AID372, Type: screening] | Chain A, Solution Structure Of The Rnase H Domain Of The Hiv-1 Reverse Transcriptase In The Presence [gi:28949057] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 8085194 | | CID | 2865685 | | Outcome | Inactive | | BioAssay | HIV-1 RNase H Inhibition | | AID | 372 | | BioAssay type | screening | | Target | Chain A, Solution Structure Of The Rnase H Domain Of The Hiv-1 Reverse Transcriptase In The Presence [gi:28949057] | | PubMed | | | Data Table |  |
|
| 26 | [SID17454090] | Inactive | | | HTS Colorimetric assay for the identification of compounds that inhibit VHR1 [AID1992, Type: screening] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | BioAssay | HTS Colorimetric assay for the identification of compounds that inhibit VHR1 | | AID | 1992 | | BioAssay type | screening | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 27 | [SID17454090] | Inactive | | | HTS Colorimetric assay for the identification of compounds that inhibit VHR1 [AID1992, Type: screening] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | BioAssay | HTS Colorimetric assay for the identification of compounds that inhibit VHR1 | | AID | 1992 | | BioAssay type | screening | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 28 | [SID17454090] | Inactive | | | Fluorescence Polarization Screen Assay for Bcl-B Phenotype Converters [AID1240, Type: screening] | nuclear receptor subfamily 4 group A member 1 [Homo sapiens] [gi:27894344] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization Screen Assay for Bcl-B Phenotype Converters | | AID | 1240 | | BioAssay type | screening | | Target | nuclear receptor subfamily 4 group A member 1 [Homo sapiens] [gi:27894344] | | PubMed | | | Data Table |  |
|
| 29 | [SID17454090] | Inactive | | | Fluorescence Polarization Screen Assay for Bcl-B Phenotype Converters [AID1240, Type: screening] | nuclear receptor subfamily 4 group A member 1 [Homo sapiens] [gi:27894344] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization Screen Assay for Bcl-B Phenotype Converters | | AID | 1240 | | BioAssay type | screening | | Target | nuclear receptor subfamily 4 group A member 1 [Homo sapiens] [gi:27894344] | | PubMed | | | Data Table |  |
|
| 30 | [SID17454090] | Inactive | | | Fluorescence Polarization Screen Assay for Bcl-B Phenotype Converters [AID1240, Type: screening] | nuclear receptor subfamily 4 group A member 1 [Homo sapiens] [gi:27894344] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17454090 | | CID | 2865685 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization Screen Assay for Bcl-B Phenotype Converters | | AID | 1240 | | BioAssay type | screening | | Target | nuclear receptor subfamily 4 group A member 1 [Homo sapiens] [gi:27894344] | | PubMed | | | Data Table |  |
|